Celyad will accelerate commercialization of the C-Cure stem cell therapy after Phase III results.
Health Care + Med Tech
But marginal increase suggests transparency program is working to temper remuneration.
Ryan Companies’ project located within retail center.
The 32 year-old private company promoted Kristen Knox, its chief operating officer.
An estimated 110 jobs will be created following the completion of the project.
Following the announcement, the med-tech company’s shares fell as much as 5 percent from its $17.77 close on Tuesday.
Blueprint Bio’s biomarker discovery platform taps personalized medicine momentum.
The first day of business coincides with the state adding intractable pain to the list of qualifying conditions.
The company’s purchase of HeartWare is an attempt to gain market share in an $800 million heart failure device market.
The hospital will provide emergency services during events.
Leave the weight-loss program. Take the standing desk.
Medical device firm would be first Minnesota IPO in nearly 18 months.
Mayo Clinic ranked as the runner-up on the national list.
The health organization hopes its latest collaboration will lead to more website traffic and a higher level of brand awareness.
A look at the Rochester clinic’s Top 10 National Institutes of Health awards.
Florida-based TapImmune exercises option, readies Phase II trials for HER2/neu cancer immunotherapy platform.
The medical device company also has another $25 million in the pipeline pending “the company’s achievement of a certain milestone.”
Regenerative, individualized medicine researchers seem likely picks for new Rochester buildings.